LONG-TERM FOLLOW-UP OF RITUXIMAB AND INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) IN COMBINATION WITH HAART IN HIV-RELATED NON-HODGKIN'S LYMPHOMAS (NHL)

被引：0
|
作者：
Spina, M.
Jaeger, U. [2 ]
Sparano, J. [3 ]
Talamini, R. [1 ]
Rossi, G. [4 ]
Vaccher, E.
Tirelli, U.
机构：
[1] Natl Canc Inst, Epidemiol Unit, Aviano, Italy
[2] Univ Vienna, Vienna, Austria
[3] Montefiore Med Ctr, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10467 USA
[4] Spedali Civili, I-25125 Brescia, Italy
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：351 / 351
页数：1
相关论文
共 50 条
  • [1] LONG-TERM FOLLOW-UP OF RITUXIMAB AND INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) IN COMBINATION WITH HAART IN HIV-RELATED NON-HODGKIN'S LYMPHOMAS (NHL)
    Spina, M.
    Jaeger, U.
    Sparano, J. A.
    Talamini, R.
    Rossi, G.
    Vaccher, E.
    Tirelli, U.
    ANNALS OF ONCOLOGY, 2011, 22 : 237 - 237
  • [2] Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIV-Related Non-Hodgkin's Lymphomas (NHL)
    Spina, Michele
    Simonelli, Cecilia
    Vaccher, Emanuela
    Jaeger, Ulrich
    Sparano, Joseph
    Talamini, Renato
    Tirelli, Umberto
    BLOOD, 2008, 112 (11) : 522 - 522
  • [3] Long-term follow-up of rituximab and infusional cyclophosphamide, doxorubicin, and etoposide (CDE) in combination with HAART in HIV-related non-Hodgkin's lymphomas (NHL)
    Spina, M.
    Simonelli, C.
    Vaccher, E.
    Jaeger, U.
    Sparano, J. A.
    Talamini, R.
    Tirelli, U.
    ANNALS OF ONCOLOGY, 2008, 19 : 151 - 152
  • [4] Long-term follow-up of rituximab and infusional cyclophosphamide, doxorubicin, and etoposide (CDE) in combination with HAART in HIV-related non-Hodgkin's lymphomas (NHL)
    Spina, M.
    Jaeger, U.
    Sparano, J. A.
    Talamini, R.
    Rossi, G.
    Vaccher, E.
    Tirelli, U.
    INFECTION, 2010, 38 : 23 - 23
  • [5] LONG-TERM FOLLOW-UP OF RITUXIMAB AND INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN COMBINATION WITH HAART IN HIV-RELATED NON-HODGKIN'S LYMPHOMAS
    Spina, M.
    Chimienti, E.
    Vaccher, E.
    Jaeger, U.
    Sparano, J. A.
    Talamini, R.
    Tirelli, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 169 - 169
  • [6] Rituximab and infusional cyclophosphamide, doxorubicin and etoposide (CDE) in combination with HAART: A safe and highly active regimen in HIV-related non-Hodgkin's lymphomas (NHL).
    Spina, M
    Simonelli, C
    Vaccher, E
    Rossi, G
    Jaeger, U
    Sparano, JA
    Tirelli, U
    BLOOD, 2003, 102 (11) : 123A - 123A
  • [7] RITUXIMAB AND INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN AND ETOPOSIDE (CDE) IN COMBINATION WITH HAART: A SAFE AND HIGHLY ACTIVE REGIMEN IN HIV-RELATED NON-HODGKIN'S LYMPHOMAS (NHL)
    Spina, Michele
    Vaccher, Emanuela
    Lleshi, Arben
    Morra, Aldo
    Rossi, Giuseppe
    Jaeger, Ulrich
    Sparano, Joseph
    Tirelli, Umberto
    ANNALS OF ONCOLOGY, 2004, 15 : 81 - 82
  • [8] Rituximab and infusional cyclophosphamide, doxorubicin and etoposide (cde) in combination with haart: a safe and highly active regimen in HIV-related non-Hodgkin's lymphomas (NHL)
    Spina, Michele
    Simonelli, Cecilia
    Vaccher, Emanuela
    Rossi, Giuseppe
    Jaeger, Ulrich
    Sparano, Joseph A.
    Tirelli, Umberto
    ANNALS OF ONCOLOGY, 2004, 15 : 153 - 153
  • [9] Pilot trial of infusional cyclophosphamide, doxorubicin, & etoposide (CDE) plus rituximab in HIV-associated non-Hodgkin's lymphoma (NHL).
    Sparano, JA
    Tirelli, U
    Hopkins, U
    Vaccher, E
    Spina, M
    BLOOD, 1999, 94 (10) : 268B - 268B
  • [10] Infusional cyclophosphamide, doxorubicin, and etoposide (CDE) for HIV-associated non-Hodgkin's lymphoma (NHL): Long-term followup and analysis of prognostic factors
    Sparano, JA
    Wiernik, PH
    Hu, XP
    Sarta, C
    Domenech, G
    Cioczek, H
    Racevskis, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 88 - 88
12345